When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.
The European Union is weighing sweeping new restrictions on children's and teenagers' access to social media, including age limits, an outright ban, and phased access. Social media platforms could also be forced to prove their services are not harmful before young people are allowed to use them. European Commission President Ursula von der Leyen said […]